2026 Buyer's Guide
Weight Loss Injections (2026): Every FDA-Approved Option
Five FDA-approved injectable medications can produce meaningful weight loss in 2026. Three (Wegovy, Zepbound, Saxenda) are FDA-approved specifically for chronic weight management. Two (Ozempic, Mounjaro) are FDA-approved for type 2 diabetes but commonly prescribed off-label for weight loss. Below: side-by-side comparison, how they work, what they cost, and where to get them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
About this page
Looking for where to get one? See the best weight loss injections, ranked by price and trust. There are separate rankings of weight loss injections for women and for men, and a board of weight loss shot names and prices.
Every drug listed below is FDA-approved with a published label on DailyMed (NIH). Mechanism, indication, administration route, dosing, and approval-date data are pulled from our primary-source-verified drug database. Cost data was verified live on July 2026 from manufacturer self-pay portals (NovoCare, LillyDirect), retailer programs (the Costco Member Prescription Program via Sesame, Sam's Club Plus and Amazon Pharmacy), and GoodRx. Our profiles of Costco Pharmacy and Sam's Club Pharmacy cover the first two of those retailer programs. We do not paraphrase indication language.
What are weight loss injections?
Every one of the five weight-loss injections on the US market today is a GLP-1 receptor agonists (one is also a GIP/GLP-1 dual agonist). They are self-administered subcutaneous injections — a small needle into the fat layer of the abdomen, thigh, or back of the upper arm — and they reduce appetite via the GLP-1 signaling pathway plus slow gastric emptying. Three are FDA-approved for chronic weight management; two are FDA-approved for type 2 diabetes and prescribed off-label for weight loss when the weight-loss-indicated drugs are unavailable, denied by insurance, or contraindicated. The class history started with Byetta (exenatide) in 2005 for type 2 diabetes; Saxenda was the first weight-management indication in December 2014; Wegovy, Zepbound, and Foundayo followed.
For the deeper biology of GLP-1 — what the hormone is, how the receptor works, and the four physiologic actions (insulin secretion, glucagon suppression, gastric emptying, central appetite suppression) — see our GLP-1 complete guide. For oral weight loss medications (Foundayo, the Wegovy tablet, Qsymia, Contrave, Xenical), see our FDA-approved weight loss medications hub (which compares pills vs injections side-by-side).
Every FDA-approved weight loss injection, compared
All five injections side-by-side. Pivotal trial efficacy cited from the canonical phase 3 publication for each drug; full PMID citations live in our bariatric vs GLP-1 decision guide.
| Brand | Generic | Indication | Guide |
|---|---|---|---|
| Wegovy | Semaglutide 2.4 mg | Weight management; CV risk reduction | Wegovy → |
| Zepbound | Tirzepatide | Weight management; OSA in obesity | Zepbound → |
| Saxenda | Liraglutide 3 mg | Chronic weight management | DailyMed → |
| Ozempic | Semaglutide (lower-dose) | Type 2 diabetes (off-label for weight loss) | Ozempic → |
| Mounjaro | Tirzepatide | Type 2 diabetes (off-label for weight loss) | Mounjaro → |
What weight loss injections cost in 2026
What a branded injection lists at swings hard depending on where you buy it. Read off the manufacturers' and retailers' own pages on May 9, 2026, except NovoCare's Wegovy prices, rechecked October 30, 2026:
Wegovy (semaglutide)
- NovoCare self-pay: $349/month (standard pen, all doses 0.25–2.4 mg; new patients pay $199 for each of their first two fills of 0.25 or 0.5 mg through December 31, 2026)
- NovoCare HD pen 7.2 mg: $399/month
- Wegovy pill (NovoCare self-pay): $149 for 1.5 mg, $199 for 4 mg, $299 for 9 or 25 mg, per month
- Costco CMPP via Sesame: $349/month (new pt $199 × 2 mo)
- Sam's Club: $499/month via copay program
- With insurance copay savings card: as little as $25/month
Zepbound (tirzepatide)
- LillyDirect vials self-pay (effective Dec 1, 2025): $299 / $399 / $449 by strength
- LillyDirect KwikPen self-pay: $299–$699 by strength
- Sam's Club KwikPen: $299/$399/$499/$699
- GoodRx coupon path: $299/month (manufacturer-funded)
Saxenda (liraglutide)
- Brand list: ~$1,300/month
- Generic liraglutide (Teva, launched August 28, 2025): pricing varies by pharmacy
- Manufacturer copay savings card: as little as $25/month for commercially insured
Ozempic (off-label) + Mounjaro (off-label)
- Ozempic NovoCare new patient: $199/mo for first 2 months; $349 standard
- Ozempic GoodRx: $149/month (oral 1.5 mg) / pen via Novo
- Mounjaro: no DTC self-pay program; copay savings card for commercial
- Off-label use is rarely insurance-covered for weight in someone without type 2 diabetes
For the live channel-by-channel pricing index across every channel + compounded options ($99–$400/mo), see our GLP-1 pricing index. IRS Publication 502 makes both branded and compounded GLP-1s HSA- and FSA-eligible once a prescription exists.
How to get a weight loss injection (telehealth, retail, insurance)
Three primary channels:
- Insurance + traditional prescriber. Your own doctor or an obesity-medicine specialist writes it, a pharmacy fills it, and your insurer decides whether its prior-authorization rules are satisfied. See our Cigna PA guide and Aetna PA guide for verbatim payer policy. Three things get under-documented more than anything else: Cigna's list of 11 qualifying comorbidities, Aetna's demand for six months of a behavioral program first, and the switch CVS Caremark made to Wegovy-preferred in July 2025.
- GLP-1 telehealth providers. An online clinic paired with a 503A pharmacy. Paying cash for compounded semaglutide or tirzepatide usually runs $99 to $400 a month. See our best semaglutide providers and best tirzepatide providers for ranked options. Direct primary care practices that dispense a GLP-1 alongside a flat monthly membership are ranked in our direct primary care GLP-1 providers board. Note: the FDA's enforcement-discretion grace period for compounded semaglutide ended February 2025 — the regulatory landscape is unsettled.
- Direct-to-consumer manufacturer pharmacies. NovoCare (Wegovy/Ozempic), LillyDirect (Zepbound/ Mounjaro/Foundayo), Costco CMPP via Sesame partner, Sam's Club Plus, Amazon Pharmacy. Cash-pay only — not eligible for insurance.
With the medicine in hand, inject the way the label says. Our step-by-step injection technique guide for every common pen and vial format, including the three FDA-approved injection sites (abdomen, thigh, back of upper arm), needle gauge, depth, angle, and the site-rotation schedule that minimizes lipohypertrophy.
Compare vetted GLP-1 telehealth providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Cash-pay pricing · HSA/FSA accepted · every partner checked by our editors
Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
Starting price: $59/mo + membership
Get started →Read review Collective →Embody
A flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Starting price: $79/mo
Get started →Read review Embody →Bodybuilding Health+
Seeing what it charges before you answer any medical questions
Starting price: $179/mo
Get started →Read review Bodybuilding Health+ →YourEra
Semaglutide at $99/month, well below the typical price
Starting price: $99/mo
Get started →Read review YourEra →Eden
Coverage in all 50 states, which most sellers will not confirm
Starting price: $99/mo
Get started →Read review Eden →Found
People who want clinician visits billed to commercial insurance, with compounded medication in the plan price
Starting price: $179/mo
Get started →Read review Found →| Provider | Starting price | |
|---|---|---|
9.1Collective | $59/mo + membership | Get started → |
9.3Embody | $79/mo | Get started → |
| $179/mo | Get started → | |
9.0YourEra | $99/mo | Get started → |
8.7Eden | $99/mo | Get started → |
7.3Found | $179/mo | Get started → |
Frequently Asked Questions
References
- 1.U.S. Food and Drug Administration / manufacturer label. Wegovy — FDA Prescribing Information: what it is licensed for, how it is dosed, and the boxed warning quoted word for word off the current label. DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- 2.U.S. Food and Drug Administration / manufacturer label. Zepbound — FDA Prescribing Information: what it is licensed for, how it is dosed, and the boxed warning quoted word for word off the current label. DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- 3.U.S. Food and Drug Administration / manufacturer label. Ozempic — FDA Prescribing Information: what it is licensed for, how it is dosed, and the boxed warning quoted word for word off the current label. DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- 4.U.S. Food and Drug Administration / manufacturer label. Mounjaro — FDA Prescribing Information: what it is licensed for, how it is dosed, and the boxed warning quoted word for word off the current label. DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- 5.U.S. Food and Drug Administration / Novo Nordisk label. Saxenda (liraglutide 3 mg) — FDA Prescribing Information: the dose ladder, what it is licensed for, and the boxed warning quoted word for word off the current label). DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
- 6.Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — ~20.9% mean body-weight reduction at 72 weeks (15 mg). New England Journal of Medicine. 2022. PMID: 35658024.
- 7.Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — ~14.9% mean body-weight reduction at 68 weeks (2.4 mg). New England Journal of Medicine. 2021. PMID: 33567185.
- 8.Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) — head-to-head superiority of tirzepatide over semaglutide. New England Journal of Medicine. 2025. PMID: 40353578.
- 9.Pi-Sunyer X, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity and Prediabetes) — ~5-8% mean body-weight reduction at 56 weeks. New England Journal of Medicine. 2015. PMID: 26132939.
- 10.Novo Nordisk. NovoCare self-pay for Wegovy and Ozempic — the cash pen prices, read off the live page in July 2026. novocare.com. 2026. https://www.novocare.com/
- 11.Eli Lilly and Company. LillyDirect self-pay for Zepbound single-dose vials — cash prices by strength, read off the live page in July 2026. lilly.com/lillydirect. 2026. https://lillydirect.lilly.com/